EMAIL THIS PAGE TO A FRIEND

International journal of pharmaceutics

TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.


PMID 25223472

Abstract

Tanshinone IIA (TAN) has few clinical applications for anti-cancer therapy mainly due to its high lipophicity, low cellular uptake, and poor bioavailability. To improve the anti-cancer effect and bioavailability of TAN, we developed a mixed micelle system constituted with D-α-tocopheryl polyethylene glycol succinate-graft-poly(D,L-lactide-co-glycolide) (TPGS-g-PLGA) copolymer and Pluronic F68. TAN was encapsulated in the TPGS-g-PLGA/Pluronic F68 mixed micelles by using the thin film hydration technology optimized by the central composite design/response surface method (CCD/RSM). TAN-loaded mixed micelles were highly stable in the presence or absence of bovine serum albumin (BSA) and achieved sustained drug release in vitro. Compared with free TAN, TAN mixed micelles had higher cytotoxicity and pro-apoptotic effects against human hepatocellular carcinoma HepG2 cells. The significant enhancement on pro-apoptosis by TAN micelles was evidenced by increased chromosome condensation, mitochondria membrane potential loss, cell apoptosis, and cleavages of caspase-3 and PARP. Furthermore, pharmacokinetic studies revealed that TAN mixed micelles significantly prolonged the circulation time and improved bioavailability of TAN in rats. These results demonstrated that TAN-loaded TPGS-g-PLGA/F68 mixed micelles are an effective strategy to deliver TAN for cancer therapy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

107700
4-(Dimethylamino)pyridine, ReagentPlus®, ≥99%
C7H10N2
39405
4-(Dimethylamino)pyridine, purum, ≥98.0% (NT)
C7H10N2
714844
4-(Dimethylamino)pyridine solution, 0.5 M in THF
C7H10N2
714720
4-(Dimethylamino)pyridine solution, 0.5 M in ethyl acetate
C7H10N2
700169
4-(Dimethylamino)pyridine, ChemDose tablets, Loading: 0.04 mmol tablet.
C7H10N2
151858
Chloroform-d, "100%", 99.96 atom % D
CCl3D
225789
Chloroform-d, 99.8 atom % D, contains 0.03 % (v/v) TMS
CCl3D
151831
Chloroform-d, 99.8 atom % D, contains 1 % (v/v) TMS
CCl3D
633267
Dicyclohexylcarbodiimide solution, 60 wt. % in xylenes
C13H22N2
685666
N,N′-Diisopropylcarbodiimide, ChemDose tablets, Loading: 0.15mmol per tablet
C7H14N2
82648
Pyrene, puriss. p.a., for fluorescence, ≥99.0% (GC)
C16H10
18868
Pyrene, certified reference material, TraceCERT®
C16H10
571245
Pyrene, sublimed grade, 99%
C16H10
185515
Pyrene, 98%
C16H10
82650
Pyrene, purum, for fluorescence, ≥97.0% (GC)
C16H10
BCR177R
Pyrene, BCR® certified Reference Material
C16H10
40082
Pyrene, certified reference material, 1000 μg/mL in methanol
C16H10
48570
Pyrene, analytical standard
C16H10
Y0001099
Valaciclovir impurity G, European Pharmacopoeia (EP) Reference Standard
C7H10N2
1707894
Valacyclovir Related Compound G, United States Pharmacopeia (USP) Reference Standard
C7H10N2